Research and Markets (http://www.researchandmarkets.com/research/57ffec/competitor_analysi)
has announced the addition of the "Competitor Analysis: BlyS, BAFF &
APRIL Antagonists" report to their offering.
“Competitor Analysis: BlyS, BAFF &
APRIL Antagonists”
The present Competitive Intelligence Report about BlyS, BAFF & APRIL
Targeted Therapy provides a competitor evaluation in the field of
molecules targeting B-lymphocyte stimulator (BlyS), B-cell activating
factor of the TNF family (BAFF) and of a proliferation-inducing ligand
(APRIL) as of February 2010. Purchase of the downloadable pdf report
includes a 6-month online access to the data of the report and any
updates since the publication date. Credentials to access the database
will be sent by e-mail and allow online work with the project data to
print or export an individual report.
The report includes a compilation of currently active projects in
research and development of antibodies and antibody-based molecules
targeting B-lymphocyte stimulator (BlyS), B-cell activating factor of
the TNF family (BAFF) and of a proliferation-inducing ligand (APRIL) for
treatment of inflammatory and autoimmune diseases such as systemic lupus
erythematosus (SLE), rheumatoid arthritis and multiple sclerosis. In
addition, the report lists company-specific R&D pipelines of PSMA & PSA
targeted therapeutics. Competitor projects are listed in a tabular
format providing information on: